Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Naturally occurring cytotoxic tumour reactive antibodies directed against type C viral envelope antigens

Abstract

TYPE C RNA viruses are frequently present in murine tumours, but the nature of the association between these viruses and malignancy is uncertain. The oncogene theory1,2 contends that type C viruses possess oncogenic information and that malignancy is the result of activation of this genetic information. Alternatively, the expression of type C viruses in a tumour may be a consequence, rather than a cause, of the neoplastic change and may be beneficial to the host by providing for potential immunological detection and eradication of neoplastic cells3. If type C viral antigens are targets for an immune surveillance mechanism, then normal animals would be expected to show evidence of immune sensitisation against viral antigens expressed on the surface of tumour cells. Here, we present evidence that naturally occurring antibodies (NOA) cytotoxic for a type C virus releasing teratoma-derived cell line are directed against viral antigens.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Huebner, R. J., and Todaro, G. J., Proc. natn. Acad. Sci. U.S.A., 64, 1087–1090 (1969).

    Article  ADS  CAS  Google Scholar 

  2. Todaro, G. J., and Huebner, R. J., Proc. natn. Acad. Sci. U.S.A., 69, 1009–1010 (1972).

    Article  ADS  CAS  Google Scholar 

  3. Martin, W. J., Cell. Immun., 15, 1–10 (1975).

    Article  CAS  Google Scholar 

  4. Ross, J. E., Scolnick, E. M., Todaro, G. J., and Aronson, S. A., Nature new Biol., 231, 163–167 (1971).

    Article  CAS  Google Scholar 

  5. Rowe, W. P., Pugh, W. E., and Hartley, J. W., Virology, 42, 1136–1139 (1970).

    Article  CAS  Google Scholar 

  6. Martin, S. E., and Martin, W. J., Proc. natn. Acad. Sci. U.S.A., 72, 1036–1040 (1975).

    Article  ADS  CAS  Google Scholar 

  7. Martin, S. E., and Martin, W. J., J. Immun. (in the press).

  8. Martin, S. E., and Martin, W. J., Int. J. Cancer, 15, 658–664, (1975).

    Article  CAS  Google Scholar 

  9. Hanna, M. G., Ihle, J. N., Batzing, B. L., Tennant, R. W., and Schenley, C. K., Cancer Res., 35, 164–171 (1975).

    PubMed  Google Scholar 

  10. Herberman, R. B., and Aoki, T., J. exp. Med., 136, 94–111 (1972).

    Article  CAS  Google Scholar 

  11. Aaronson, S. A., and Stephenson, J. R., Proc. natn. Acad. Sci. U.S.A., 71, 1957–1961 (1974).

    Article  ADS  CAS  Google Scholar 

  12. Sato, H., Boyse, E. A., Aoki, T., Iritani, C., and Old, L. J., J. exp. Med., 138, 593–606 (1973).

    Article  CAS  Google Scholar 

  13. Martin, W. J., and Martin, S. E., Nature, 249, 564–565 (1974).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MARTIN, S., MARTIN, W. Naturally occurring cytotoxic tumour reactive antibodies directed against type C viral envelope antigens. Nature 256, 498–499 (1975). https://doi.org/10.1038/256498a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/256498a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing